The past 20 years of LIM have marked growth and development for the joint physician-scientist training program. With highly motivated students completing graduate work in diverse areas, from Neurosciences to anthropology, microbiology to community health sciences, the LIM program reflects the varied interests of the physician-scientist-and important areas of research within the University of Calgary. Through the LIM program, completion of an MD jointly with a PhD, MSc, MA, MBA or JD is possible. Furthermore, MD students who have previously completed graduate level training or who are pursuing research while in the MD program are supported through LIM.
Introduction:
Opioids are revered for their potent analgesic effects; however, prolonged use can result in a severe withdrawal syndrome upon cessation of opioid use. Opioid withdrawal is characterized by a host of intensely unpleasant signs and symptoms, including somatic and autonomic physical symptoms and an unpleasant affective component. As a result, individuals are motivated to continue using opioids to avoid these severe and unpleasant episodes of withdrawal. In a previous study, we identified the pannexin-1 (Panx1) channel as a critical substrate of opioid withdrawal. Here, we investigated the efficacy of probenecid, a broad spectrum Panx1blocker currently approved as an anti-gout medication, as a therapeutic agent for combating the symptoms of opioid withdrawal.
Methods:
We established a model of opioid withdrawal by treating mice and rats with escalating doses of morphine or fentanyl. On the final day of treatment, we injected naloxone to rapidly precipitate withdrawal behaviours. To test the therapeutic effects of probenecid on opioid withdrawal, we administered a single dose of probenecid prior to naloxoneprecipitated withdrawal.
Results:
We found that both morphine and fentanyl dosing paradigms produced a robust withdrawal syndrome in mice and rats. Furthermore, an acute injection of probenecid immediately prior to naloxone-precipitated withdrawal significantly attenuated withdrawal symptoms. Most notably, probenecid reduced jumping, wetdog shakes, teeth chattering and tremor behaviours in rodents.
Conclusion:
These results suggest that probenecid may represent a viable therapeutic option for treating withdrawal in opioid dependent patients. The unpleasant symptoms of withdrawal are a major driving force for continued opioid use, and by reducing the severity of these adverse effects, we aim to assist individuals in discontinuing opioid use.
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Is prehospital care supported by evidence-based guidelines? A quality appraisal using AGREE II Conclusion: There are few high-quality, evidence-based guidelines in EMS. Of the published guidelines, the majority fail to meet established quality measures. Although a lack of randomized controlled trials conducted in the prehospital field continues to limit guideline development, suboptimal methodology is also commonplace within the existing literature. 
Methods:
We employ the lysolecithin model of focal toxic demyelination. Animals are individually housed in rat cages modified to contain a running wheel. Wheel revolutions are recorded by custom computer software.
Results:
Immediate therapeutic access to a running wheel enhanced oligodendrocyte generation. In exercising animals, we observed a 40% increase in oligodendrocyte progenitor proliferation resulting in the production of 36% more mature oligodendrocytes. Moreover, in exercising animals, 48% more myelin basic protein was expressed, a 2.11-fold increase in remyelinated axons was seen, the myelin generated was thicker than controls, and the number of unmyelinated axons decreased from 51% to 13%. We identify peroxisome proliferator activated receptor gamma (PPAR) co-activator-1-α(PGC1α) within oligodendrocytes as a transiently expressed and exercise-induced factor that is required for the enhancement of myelin thickness by exercise. RNA-sequencing demonstrated increased axonal activity/neurotransmission as well as intracellular calcium and phosphatidylinositol signalling, suggesting a broad activation of pro-myelination pathways in the enhancement of remyelination by exercise. Finally, we demonstrated that exercise worked in parallel with the novel remyelinating medication, clemastine, to further potentiate therapeutic remyelination and increase the total number of axons within lesions, indicating that the combination enhanced the protection of axons from acute, demyelination-induced degeneration.
Conclusion:
This study demonstrated that physical exercise was an efficacious, integrative means to enhance remyelination, and detailed a PGC1α-dependent mechanism through which oligodendrocytes accelerated myelin production in response to activity. Methods: Matrix-assisted laser desorption/ionization-mass spectrometry imaging was used to acquire spectral data from human DN and HN kidney biopsies. Spectral data was analyzed for analytical reproducibility and to identify m/z values more abundant in DN or HN.
Precision
Results: Analytical variability was minimal between replicates. Significant differences in the tryptic peptide profiles of DN and HN were visible. Through ROC analysis we identified 25 m/z peaks were more abundant in DN and 5 m/z peaks more abundant in HN.
Conclusion:
Our analytical protocol is robust and sensitive to detect differences in protein signatures between DN and HN. Future studies will be performed in an expanded cohort to validate these results. The discovery of biomarkers will potentially improve resource allocation, health care delivery and the outcome of patients with CKD. Introduction: Major depressive disorder (MDD) has been identified to have a direct effect on cytokines, including increased TNFα levels relative to healthy controls. As these increased inflammatory markers are often seen in autoimmune diseases such as rheumatoid arthritis (RA), our aim was to explore whether MDD is a risk factor for the development of RA.
Major depressive disorder as a risk factor for
Methods: A retrospective cohort study was conducted using The Health Improvement Network (THIN) database . Both the MDD and referent cohorts were followed until patients developed RA or were censored. Cox proportional hazards models were used to determine the risk of developing RA among patients with MDD, accounting for age and sex.
Results: A cohort of 403,932 patients with MDD and a referent cohort of 5,339,399 patients without diagnostic codes for MDD were identified in THIN. Cox proportional hazards models revealed a significant interaction by age (p<0.0001), whereby younger patients with MDD (age<40 years) had a 42% increased risk of developing RA (HR=1.42, 95%CI: 1.31-1.53). In older patients (age>40 years), the risk of developing RA among those with MDD was lower but demonstrated a 14% increased risk (HR=1.14, 95%CI: 1.08-1.21).
Conclusion:
MDD was found to be a risk factor for the development of RA. This risk was highest among younger patients with MDD, and the risk was only somewhat increased among older patients with MDD. These results provide support for the inflammatory hypothesis that MDD may be associated with the development of RA. Methods: This quasi-experimental study was guided by Graham's KT framework and took place in one acute care unit, out-patient heart function clinic, primary care clinic and cardiac homecare team. Clinicians/managers from each setting were partnered with the researchers and with three AHS teams (Alberta Improvement Way, e-Simulation and ACP education) to define goals and to identify ACP processes, root cause analysis for gaps and targets to create improvement. The teams brainstormed solutions to improve and enhance conversations and documentation flow and used a matrix to prioritize strategies. Over three-months, teams implemented higher impact, lower effort changes. Outcome measurements were collected by a validated patient survey and chart audits bi-weekly pre-, during and postintervention period.
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Results: This project confirmed the feasibility and utility of utilizing existing resources to engage clinical teams in a change management intervention using a KT framework. . Additionally, zinc supplementation has been found to improve mental health and, in animal models, zinc deficiency has been shown to alter the microbial environment of the gut. This project is investigating associations between zinc (intake and physiological levels), cognitive flexibility, anxiety, depression and OCD symptoms and the gut microbiota, in youth with and without OCD. It will also explore the effects of prebiotic supplementation for youth with OCD, with respect to symptoms and gut microbial diversity.
Methods: Zinc status analysis is via intake (3-day dietary record), as well as serum and hair levels. Mental measures include interview and self-report symptom questionnaires, and cognitive flexibility testing. Gut microbiota analysis is via qPCR with 16S rRNA sequencing of stool samples. Youth with OCD are also given a prebiotic or placebo supplement (double-blind RCT) for 8 weeks. Data will be compared for youth with vs. without OCD, and pre-vs. post intervention.
Results: Recruitment is ongoing, with participants with OCD having unique sample challenges compared with healthy controls.
Conclusion:
Nutritional status' impact on mental health is underexplored. No literature to date combines analysis of zinc, cognitive flexibility, and gut microbiota, particularly in OCD. This research has potential to aid development of adjunct OCD therapy for youth.
Undergraduate medical students' experiences with social studying and learning D Keren, J Lockyer, M Kelly, N Chick, R Ellaway Cumming School of Medicine and Taylor Institute for Teaching, University of Calgary, Calgary, AB Introduction: Medical students study in social groups, which influences their learning, but few studies have investigated the influence of social studying and learning (SSL) on medical students' educational experiences. This study aimed to improve our understanding of students' experiences with SSL, their perceptions of the role of this learning tool in their education, and what barriers students may face in utilizing SSL.
Methods: This qualitative study employed grounded theory methodology through a sensitizing lens of phenomenology to better understand students' experiences. Semi-structured in-depth interviews were conducted with 23 students within a single medical school cohort at the University of Calgary, regarding their experiences with SSL. Data collection and analysis were conducted iteratively through paired and parallel coding until saturation was reached.
Results: Three emergent theories were generated: (1) there is a culture and belief system around SSL in medical school, which is propagated by faculty and students; (2) social and academic privilege-or lack of it-influence students' ability to access and utilize SSL; and (3) there is a reciprocal relationship between SSL and student experiences of social isolation.
This study demonstrates a clear role for SSL in medical school and highlights the implications of this on medical students' experiences. By demonstrating both a significant variation in the accessibility of SSL to different students and a clear relationship between SSL and student wellbeing, the results from this study are implicated in discourses regarding medical student resiliency and welfare. Ultimately, a better understanding of how SSL influences students' experiences in medical school will better enable medical educators to support and guide their students. Morphine is a potent opioid analgesic used in the treatment of moderate to severe pain; however, individual responses to morphine are highly variable. By understanding the biological changes that alter the response to morphine, we may be able to better predict opioid responders. Growing evidence suggests that microglia are involved in modulating the response to opioids. In the present study, we examined the analgesic response to morphine and how it is modulated by prolonged microglial reactivity.
Methods:
Male and female wild-type and knock-out mice were treated with morphine (10 mg/kg, or an escalating dose response 2.5-40 mg/kg; IP) and anti-nociception was measured using thermal tail withdrawal test. Microglial reactivity was assessed using immune histochemical labelling of microglial and inflammatory cytokine analysis using quantitative PCR.
Results: Male knock-out mice had prolonged microglial reactivity compared with wild-type controls. In wild-type mice, acute response to morphine produced a robust antinociceptive response, reaching about 90% of the maximum possible effect; however, in knock-out mice, only 40% MPE was achieved. In contrast, in female mice, there was no evidence of ongoing microglial reactivity, and no difference in the antinociceptive response to morphine. We also found that ongoing microglial reactivity in male knock-out mice exacerbated the development of side effects to repeated morphine treatment.
Conclusion:
We characterized a mouse model where microglial reactivity was altered in male but not female mice. The microglial changes diminish the analgesic effects of morphine and exacerbate the development of side effects with repeated exposure. By gaining an understanding of the role of microglia in opioid analgesia we may be able to predict opioid responders, thereby minimizing unnecessary opioid trials and decreasing the development of severe side effects. 
Introduction:
Single-entry models (SEMs) in healthcare are a waiting time management strategy that can improve accessibility to scheduled clinical services. Impact on overall quality of care is poorly understood. We evaluated the Winnipeg Central Intake Service (WCIS), a SEM for patients referred for total hip (THR) or knee replacement (TKR).
Methods:
A pre/post-intervention cross-sectional design was used to measure changes in six dimensions of quality of care (Alberta Quality Matrix for Health): acceptability; accessibility; appropriateness; effectiveness; efficiency; and safety. Two cohorts were identified using the regional THR and TKR waitlist. Pre-WCIS (n=2,282) and post-WCIS cohorts (n=2,397) were compared before and after WCIS implementation. Primary outcomes were waiting time (WT) variation across surgeons, waiting times (WT1 primary care to specialist referral; WT2 decision to treat until surgery; and TW total waiting time), and proportion of surgeries within benchmark. Analysis included descriptive statistics, Student's t and chi-square tests and clustered regression analyses (by surgeon).
Results:
Compared with pre-implementation, most orthopedic surgeons experienced a reduction in WT variation for WT1, WT2 and TW following the introduction of the WCIS. Variability in TW was reduced among surgeons by 3.7 (hip) and 4.3 (knee) weeks. Mean WTs for THR (WT1) and TKR (WT1/WT2/TW) were also reduced. The proportion of patients who underwent TKR, within benchmark, increased by 5.9%. Among the quality dimensions, only accessibility and safety changed (post-WCIS, THR and TKR). Regression analysis revealed shorter WT2 was associated with post-WCIS (knee), worse Oxford score (hip and knee) and having medical comorbidities (hip). Meeting benchmark WTs was associated with post-WCIS
